About Methotrexate-associated lymphoproliferative disorders
Methotrexate-associated lymphoproliferative disorders is a rare disease catalogued by Orphanet (ORPHA:86904). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to Methotrexate-associated lymphoproliferative disorders trials.
Search ClinicalTrials.gov for "Methotrexate-associated lymphoproliferative disorders" or Orphanet code ORPHA:86904 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting Methotrexate-associated lymphoproliferative disorders trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Methotrexate-associated lymphoproliferative disorders. Updated daily.